Terms: = Bone cancer AND DUX4L1, DUX4, P0CJ90, P0CJ89, P0CJ88, P0CJ86, P0CJ85, 22947 AND Treatment
10 results:
1. KDM2B-Rearranged Soft Tissue Sarcomas Expand the Concept of BCOR-Associated Sarcoma.
Motoi T; Hirata M; Kukita Y; Satomi K; Tamura H; Adachi S; Matsushita Y; Horiguchi SI; Hishima T; Ikegami M; Okuma T; Tao K; Arakawa A; Ogawa C; Matsuda K; Ichimura K; Nakamura H; Mori T; Yoshida A
Mod Pathol; 2023 Nov; 36(11):100317. PubMed ID: 37634866
[TBL] [Abstract] [Full Text] [Related]
2. Clinicopathological features of five cases of CIC::dux4 positive sarcomas, including literature review.
Rekhi B; Rumdee R; Shetty O
Ann Diagn Pathol; 2023 Aug; 65():152153. PubMed ID: 37167753
[TBL] [Abstract] [Full Text] [Related]
3. A global collaboRAtive study of CIC-rearranged, BCOR::CCNB3-rearranged and other ultra-rare unclassified undifferentiated small round cell sarcomas (GRACefUl).
Palmerini E; Gambarotti M; Italiano A; Nathenson MJ; Ratan R; Dileo P; Provenzano S; Jones RL; DuBois SG; Martin-Broto J; de Alava E; Baldi GG; Grignani G; Ferraresi V; Brunello A; Paoluzzi L; Bertulli R; Hindi N; Montemurro M; Rothermundt C; Cocchi S; Salguero-Aranda C; Donati D; Martin JD; Abdelhamid Ahmed AH; Mazzocca A; Carretta E; Cesari M; Pierini M; Righi A; Sbaraglia M; Laginestra MA; Scotlandi K; Dei Tos AP; Ibrahim T; Stacchiotti S; Vincenzi B
Eur J Cancer; 2023 Apr; 183():11-23. PubMed ID: 36791667
[TBL] [Abstract] [Full Text] [Related]
4. Patterns of care and outcome of CIC-rearranged sarcoma patients: A nationwide study of the French sarcoma group.
Brahmi M; Gaspar N; Gantzer J; Toulmonde M; Boudou-Rouquette P; Bompas E; Firmin N; Valentin T; Cancel M; Duffaud F; Bertucci F; Perrin C; Dufresne A; Marec-Bérard P; Jean-Denis M; Ray-Coquard I; Le Loarer F; Pierron G; Tirode F; Blay JY; Watson S
Cancer Med; 2023 Apr; 12(7):7801-7807. PubMed ID: 36537582
[TBL] [Abstract] [Full Text] [Related]
5. A phase II trial of regorafenib in patients with advanced Ewing sarcoma and related tumors of soft tissue and bone: SARC024 trial results.
Attia S; Bolejack V; Ganjoo KN; George S; Agulnik M; Rushing D; Loggers ET; Livingston MB; Wright J; Chawla SP; Okuno SH; Reinke DK; Riedel RF; Davis LE; Ryan CW; Maki RG
Cancer Med; 2023 Jan; 12(2):1532-1539. PubMed ID: 35950293
[TBL] [Abstract] [Full Text] [Related]
6. Analysis of dux4 Expression in bone Marrow and Re-Discussion of dux4 Function in the Health and Disease.
Hangul C; Tokta O; Karauzum SB; Akkaya B; Yildirim H; Kupesiz FT; Akinel AN
Turk Patoloji Derg; 2022; 38(3):219-226. PubMed ID: 34854471
[TBL] [Abstract] [Full Text] [Related]
7. Novel fusion sarcomas including targetable NTRK and ALK.
Chen T; Wang Y; Goetz L; Corey Z; Dougher MC; Smith JD; Fox EJ; Freiberg AS; Flemming D; Fanburg-Smith JC
Ann Diagn Pathol; 2021 Oct; 54():151800. PubMed ID: 34464935
[TBL] [Abstract] [Full Text] [Related]
8. Imaging features and clinical course of undifferentiated round cell sarcomas with CIC-dux4 and BCOR-CCNB3 translocations.
Brady EJ; Hameed M; Tap WD; Hwang S
Skeletal Radiol; 2021 Mar; 50(3):521-529. PubMed ID: 32840647
[TBL] [Abstract] [Full Text] [Related]
9. Undifferentiated round cell sarcomas with CIC-dux4 gene fusion: expanding the clinical spectrum.
Brčić I; Brodowicz T; Cerroni L; Kashofer K; Serbanescu GL; Kasseroler MT; Amann G; Scheipl S; Szkandera J; Leithner A; Liegl-Atzwanger B
Pathology; 2020 Feb; 52(2):236-242. PubMed ID: 31870501
[TBL] [Abstract] [Full Text] [Related]
10. High-grade undifferentiated small round cell sarcoma with t(4;19)(q35;q13.1) CIC-dux4 fusion: emerging entities of soft tissue tumors with unique histopathologic features--a case report and literature review.
Haidar A; Arekapudi S; DeMattia F; Abu-Isa E; Kraut M
Am J Case Rep; 2015 Feb; 16():87-94. PubMed ID: 25683183
[TBL] [Abstract] [Full Text] [Related]
